Cardio-Protective Effects of Omega-3 LCPUFA in Percutaneous Coronary Intervention Reperfusion Therapy after ST-Segment Elevation Acute Myocardial Infarction
This article at a glance
- Acute myocardial infarction (AMI) remains one of the most common causes of death globally.
- The study reports the results of an observational study of Japanese patients who had a STEMI-type AMI and that received percutaneous coronary intervention (PCI) reperfusion therapy.
- The results indicate that people who had EPA + DHA levels in serum over 155 mg/ml had a markedly better outcome of PCI than people with low omega-3 LCPUFA levels; ischemia-reperfusion injury was decreased as measured by fewer reperfusion ventricular arrhythmias, lower ST-segment re-elevation, and less myocardial tissue injury.